Table 2.
Summary of neutralization antibody titers of two anti-bovine rotaviruses A (RVA) immunoglobulins Ys (IgYs) and one control IgY against ten bovine RVA isolates.
| IgY | Genotype | Neutralization Antibody titer of Three IgYs against Bovine RVA with Different Genotypes a | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SMN-1 | HKD18 | SMN35 | HKD6 | HKD7 | HKD17 | KK-3 | OKY31 | MYG-1 | Dai-10 | ||
| G6P[1] | G6P[5] | G6P[5] | G6P[11] | G6P[11] | G6P[11] | G10P[11] | G10P[11] | G8P[14] | G24P[33] | ||
| Anti-SMN35 IgY | G6P[5] | 2560 | 2560 | 5120 | 1280 | 1280 | 1280 | 160 | 80 | 80 | <80 |
| Anti-OKY31 IgY | G10P[11] | <160 | 320 | 160 | 640 | 640 | 640 | 2560 | 2560 | <80 | <80 |
| Control IgY | <20 | <20 | <20 | <20 | <20 | <20 | <20 | <20 | <20 | <20 | |
a IgY titer is expressed as dilution factor of 1 g hyperimmunized IgY powder that showed inhibition of cytopathic effects (CPE) or, in other words, that protected >50% of cells from CPE. Results are presented as the mean of three independent experiments.